Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Status: Enrolling
Updated:  1/18/2016
Allergy & Asthma Consultants of Rockland & Bergen
mi
from
West Nyack, NY
Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Status: Enrolling
Updated: 1/18/2016
Allergy & Asthma Consultants of Rockland & Bergen
mi
from
West Nyack, NY
Click here to add this to my saved trials
Ventilator Adapters for Combivent Respimat
Open Label, Non-randomised, 1-day Trial to Characterize the Performance of Two Adapter Devices Designed to Permit Use of the Respimat® Inhaler Device With Patients Requiring Mechanical Ventilation.
Status: Enrolling
Updated:  1/19/2016
205.452.01199 Boehringer Ingelheim Investigational Site
mi
from
Danbury, CT
Ventilator Adapters for Combivent Respimat
Open Label, Non-randomised, 1-day Trial to Characterize the Performance of Two Adapter Devices Designed to Permit Use of the Respimat® Inhaler Device With Patients Requiring Mechanical Ventilation.
Status: Enrolling
Updated: 1/19/2016
205.452.01199 Boehringer Ingelheim Investigational Site
mi
from
Danbury, CT
Click here to add this to my saved trials
Ventilator Adapters for Combivent Respimat
Open Label, Non-randomised, 1-day Trial to Characterize the Performance of Two Adapter Devices Designed to Permit Use of the Respimat® Inhaler Device With Patients Requiring Mechanical Ventilation.
Status: Enrolling
Updated:  1/19/2016
1199.15.10110 Boehringer Ingelheim Investigational Site
mi
from
Fort Worth, TX
Ventilator Adapters for Combivent Respimat
Open Label, Non-randomised, 1-day Trial to Characterize the Performance of Two Adapter Devices Designed to Permit Use of the Respimat® Inhaler Device With Patients Requiring Mechanical Ventilation.
Status: Enrolling
Updated: 1/19/2016
1199.15.10110 Boehringer Ingelheim Investigational Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Telemedicine Interventions for Obstructive Sleep Apnea (OSA)
An RCT of Telemedicine Interventions for OSA
Status: Enrolling
Updated:  1/20/2016
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Telemedicine Interventions for Obstructive Sleep Apnea (OSA)
An RCT of Telemedicine Interventions for OSA
Status: Enrolling
Updated: 1/20/2016
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Click here to add this to my saved trials
Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)
Phase I/II Study to Determine the Safety and Efficacy of Quercetin in COPD Patients
Status: Enrolling
Updated:  1/20/2016
University of Michigan
mi
from
Ann Arbor, MI
Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)
Phase I/II Study to Determine the Safety and Efficacy of Quercetin in COPD Patients
Status: Enrolling
Updated: 1/20/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Joliet, IL
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Joliet, IL
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Maywood, IL
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Maywood, IL
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Sacramento, CA
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Jacksonville, FL
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Chicago, IL
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Wichita, KA
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Minneapolis, MN
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
New York, NY
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Cincinnati, OH
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Clinical Research Facility
mi
from
Charleston, SC
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  1/22/2016
Site Reference ID/Investigator# 8941
mi
from
Edmonton,
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 1/22/2016
Site Reference ID/Investigator# 8941
mi
from
Edmonton,
Click here to add this to my saved trials
Pharmacogenetics of Doxazosin for Cocaine Dependence
H-26605: Pharmacogenetics of Doxazosin for Cocaine Dependence
Status: Enrolling
Updated:  1/25/2016
Baylor College of Medicine
mi
from
Houston, TX
Pharmacogenetics of Doxazosin for Cocaine Dependence
H-26605: Pharmacogenetics of Doxazosin for Cocaine Dependence
Status: Enrolling
Updated: 1/25/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Adjusting to Chronic Conditions Using Education, Support, and Skills
Cognitive Behavioral Therapy in Primary Care: Treating the Medically Ill
Status: Enrolling
Updated:  1/25/2016
VA Medical Center, Oklahoma City
mi
from
Oklahoma City, OK
Adjusting to Chronic Conditions Using Education, Support, and Skills
Cognitive Behavioral Therapy in Primary Care: Treating the Medically Ill
Status: Enrolling
Updated: 1/25/2016
VA Medical Center, Oklahoma City
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Adjusting to Chronic Conditions Using Education, Support, and Skills
Cognitive Behavioral Therapy in Primary Care: Treating the Medically Ill
Status: Enrolling
Updated:  1/25/2016
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Adjusting to Chronic Conditions Using Education, Support, and Skills
Cognitive Behavioral Therapy in Primary Care: Treating the Medically Ill
Status: Enrolling
Updated: 1/25/2016
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Click here to add this to my saved trials
Caffeine to Reduce Mechanical Ventilation in Preterm Infants
Use of Caffeine to Reduce Length of Mechanical Ventilation in Preterm Infants
Status: Enrolling
Updated:  1/25/2016
NICU, Holtz Children's Hospital, Jackson Health System
mi
from
Miami, FL
Caffeine to Reduce Mechanical Ventilation in Preterm Infants
Use of Caffeine to Reduce Length of Mechanical Ventilation in Preterm Infants
Status: Enrolling
Updated: 1/25/2016
NICU, Holtz Children's Hospital, Jackson Health System
mi
from
Miami, FL
Click here to add this to my saved trials
Combined Treatment for Cocaine-Alcohol Dependence - 1
Combined Treatment for Cocaine-Alcohol Dependence
Status: Enrolling
Updated:  1/25/2016
University of Texas Health Sci Cntr Houston
mi
from
Houston, TX
Combined Treatment for Cocaine-Alcohol Dependence - 1
Combined Treatment for Cocaine-Alcohol Dependence
Status: Enrolling
Updated: 1/25/2016
University of Texas Health Sci Cntr Houston
mi
from
Houston, TX
Click here to add this to my saved trials
MD2Me - Texting to Promote Chronic Disease Management
TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management
Status: Enrolling
Updated:  1/25/2016
The University of California, San Diego
mi
from
La Jolla, CA
MD2Me - Texting to Promote Chronic Disease Management
TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management
Status: Enrolling
Updated: 1/25/2016
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine
Magnetic Resonance Imaging and Neurodevelopmental Outcomes in Preterm Infants Following Administration of High-Dose Caffeine - A Pilot Study
Status: Enrolling
Updated:  1/26/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine
Magnetic Resonance Imaging and Neurodevelopmental Outcomes in Preterm Infants Following Administration of High-Dose Caffeine - A Pilot Study
Status: Enrolling
Updated: 1/26/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Detecting Post-Operative Respiratory Depression in Children
Detecting Post-Operative Respiratory Depression in Children: Are Our Current Standards Good Enough?
Status: Enrolling
Updated:  1/26/2016
Yale-New Haven Children's Hospital
mi
from
New Haven, CT
Detecting Post-Operative Respiratory Depression in Children
Detecting Post-Operative Respiratory Depression in Children: Are Our Current Standards Good Enough?
Status: Enrolling
Updated: 1/26/2016
Yale-New Haven Children's Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
UCLA Integrated Substance Abuse Programs (ISAP)
mi
from
Los Angeles, CA
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
UCLA Integrated Substance Abuse Programs (ISAP)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
Bay Area Addiction Research and Treatment (BAART)
mi
from
San Francisco, CA
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
Bay Area Addiction Research and Treatment (BAART)
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
Addiction Research and Treatment Services (ARTS)
mi
from
Denver, CO
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
Addiction Research and Treatment Services (ARTS)
mi
from
Denver, CO
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
Howard University Hospital
mi
from
Washington,
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
Howard University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
Albert Einstein College of Medicine - Division of Substance Abuse
mi
from
Bronx, NY
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
Albert Einstein College of Medicine - Division of Substance Abuse
mi
from
Bronx, NY
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
Bellevue Hospital Center
mi
from
New York, NY
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
Bellevue Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
Maryhaven
mi
from
Columbus, OH
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
Maryhaven
mi
from
Columbus, OH
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
CODA, Inc.
mi
from
Portland, OR
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
CODA, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
South Texas Veterans Health Care System
mi
from
San Antonio, TX
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
South Texas Veterans Health Care System
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
Recovery Centers of King County (RCKC)
mi
from
Seattle, WA
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
Recovery Centers of King County (RCKC)
mi
from
Seattle, WA
Click here to add this to my saved trials
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated:  1/27/2016
Atlanta VA Medical Center
mi
from
Atlanta, GA
Cocaine Use Reduction With Buprenorphine
Cocaine Use Reduction With Buprenorphine (CURB)
Status: Enrolling
Updated: 1/27/2016
Atlanta VA Medical Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
Innate and Adaptive Immunity in COPD Exacerbations: Prospective Cohort Study
Status: Enrolling
Updated:  1/28/2016
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
Innate and Adaptive Immunity in COPD Exacerbations: Prospective Cohort Study
Status: Enrolling
Updated: 1/28/2016
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Innate and Adaptive Immunity in COPD Exacerbations: Surgical Volunteers
Status: Enrolling
Updated:  1/28/2016
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Innate and Adaptive Immunity in COPD Exacerbations: Surgical Volunteers
Status: Enrolling
Updated: 1/28/2016
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Innate and Adaptive Immunity in COPD Exacerbations: Surgical Volunteers
Status: Enrolling
Updated:  1/28/2016
VA Ann Arbor Healthcare System
mi
from
Ann Arbor, MI
T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Innate and Adaptive Immunity in COPD Exacerbations: Surgical Volunteers
Status: Enrolling
Updated: 1/28/2016
VA Ann Arbor Healthcare System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Innate and Adaptive Immunity in COPD Exacerbations: Severe AE-COPD Clinical Course Study
Status: Enrolling
Updated:  1/28/2016
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Innate and Adaptive Immunity in COPD Exacerbations: Severe AE-COPD Clinical Course Study
Status: Enrolling
Updated: 1/28/2016
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury
Status: Enrolling
Updated:  1/28/2016
Grady Memorial Hospital
mi
from
Atlanta, GA
Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury
Status: Enrolling
Updated: 1/28/2016
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury
Status: Enrolling
Updated:  1/28/2016
Emory Crawford Long Hospital
mi
from
Atlanta, GA
Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury
Status: Enrolling
Updated: 1/28/2016
Emory Crawford Long Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury
Status: Enrolling
Updated:  1/28/2016
Emory University Hospital
mi
from
Atlanta, GA
Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury
Status: Enrolling
Updated: 1/28/2016
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury
Status: Enrolling
Updated:  1/28/2016
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury
Status: Enrolling
Updated: 1/28/2016
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Genetic and Environmental Characteristics of Primary Pulmonary Hypertension
Genetic and Environmental Pathogenesis of PPH
Status: Enrolling
Updated:  2/1/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Genetic and Environmental Characteristics of Primary Pulmonary Hypertension
Genetic and Environmental Pathogenesis of PPH
Status: Enrolling
Updated: 2/1/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Stress, Environment, and Genetics in Urban Children With Asthma
Stress, Environment, and Genetics in Urban Asthma
Status: Enrolling
Updated:  2/2/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Stress, Environment, and Genetics in Urban Children With Asthma
Stress, Environment, and Genetics in Urban Asthma
Status: Enrolling
Updated: 2/2/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Model-Based Image Reconstruction for X-Ray CT in Lung Imaging
Model-Based Image Reconstruction for X-Ray CT in Lung Imaging
Status: Enrolling
Updated:  2/3/2016
University of Michigan Hospital
mi
from
Ann Arbor, MI
Model-Based Image Reconstruction for X-Ray CT in Lung Imaging
Model-Based Image Reconstruction for X-Ray CT in Lung Imaging
Status: Enrolling
Updated: 2/3/2016
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Intermittent Versus Continuous Infusion Meropenem in Cystic Fibrosis
A Comparison of the Effect of Intermittent and Continuous Infusion of Meropenem on the Prevalence of Nausea in Pediatric Cystic Fibrosis Patients
Status: Enrolling
Updated:  2/4/2016
Dayton Children's Hospital
mi
from
Dayton, OH
Intermittent Versus Continuous Infusion Meropenem in Cystic Fibrosis
A Comparison of the Effect of Intermittent and Continuous Infusion of Meropenem on the Prevalence of Nausea in Pediatric Cystic Fibrosis Patients
Status: Enrolling
Updated: 2/4/2016
Dayton Children's Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Multicenter, Randomized, Open Label Trial to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Status: Enrolling
Updated:  2/5/2016
Banner University Medical Center Phoenix Advanced Lung Disease
mi
from
Phoenix, AZ
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Multicenter, Randomized, Open Label Trial to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Status: Enrolling
Updated: 2/5/2016
Banner University Medical Center Phoenix Advanced Lung Disease
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Multicenter, Randomized, Open Label Trial to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Status: Enrolling
Updated:  2/5/2016
University of California, Los Angeles - Pulmonary Division
mi
from
Los Angeles, CA
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Multicenter, Randomized, Open Label Trial to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Status: Enrolling
Updated: 2/5/2016
University of California, Los Angeles - Pulmonary Division
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Multicenter, Randomized, Open Label Trial to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Status: Enrolling
Updated:  2/5/2016
University of California - Davis Medical Group
mi
from
Sacramento, CA
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Multicenter, Randomized, Open Label Trial to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Status: Enrolling
Updated: 2/5/2016
University of California - Davis Medical Group
mi
from
Sacramento, CA
Click here to add this to my saved trials